Rockwood Clinic is conducting a research study to assess the effectiveness of atomoxetine, an approved medication in an investigational use, versus placebo (an inactive, look-alike pill) in reducing symptoms in children or adolescents with attention-deficit/hyperactivity disorder (ADHD) and/or dyslexia.
Your child may qualify for this study if they:
- Are at least 10 years old and no more than 16 years old
- Meet criteria for a diagnosis of ADHD and/or dyslexia
- Are able to swallow capsules
- Are willing to use a reliable method of birth control during the study
Qualified participants will receive the following at no charge:
- Study-related physical exams, labs, and ADHD testing
- Study medications
- Travel compensation
If you are interested in learning more about this study or to find out if your child may qualify, please contact Jaime -at (509) 755-6882.
Principal Investigator
Stephen Luber, M.D. (refer to CT1L study)